Replies to post #2038 on Tetraphase Pharmaceuticals, Inc. (TTPH)

[rufustherat]

Probably worth $4-$5 a share at least, cash value is about $3.25 a share. Hopefully there will be some run up to PDUFA, bail out then, in the mean time could sell covered calls.

Agree options are not the greatest, but the the $5 PPS was without the expectation of a positive cUTI trial